Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease - Wikidata - awgldk - TriplyDB

Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease

Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease

http://www.wikidata.org/entity/Q28360085

about

A Systems Pharmacology Approach to Determine Active Compounds and Action Mechanisms of Xipayi KuiJie'an enema for Treatment of Ulcerative colitis.The functional -765G→C polymorphism of the COX-2 gene may reduce the risk of developing crohn's disease Nitric oxide-induced cellular stress and p53 activation in chronic inflammation Role of cyclooxygenases 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice.Intrinsic primary afferent neurones of the digestive tract.Plasticity of the enteric nervous system during intestinal inflammation.Regulatory effects of glycyrrhizae radix extract on DSS-induced ulcerative colitis Pain management in patients with inflammatory bowel disease: insights for the clinician Ixeris dentata NAKAI Reduces Clinical Score and HIF-1 Expression in Experimental Colitis in Mice.Neuroanatomy of lower gastrointestinal pain disorders Neuroplasticity and dysfunction after gastrointestinal inflammation.Colonic motility in ulcerative colitis Cytokine expression of microscopic colitis including interleukin-17.Glycyrrhetic Acid Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Vivo.The GPR55 antagonist CID16020046 protects against intestinal inflammation.Selective cyclooxygenase-2 inhibitor ameliorates cholecystokinin-octapeptide-induced acute pancreatitis in rats.TNF-alpha hyperpolarizes membrane potential and potentiates the response to nicotinic receptor stimulation in cultured rat myenteric neurones.Upregulation of cyclooxygenase-2 and thromboxane A2 production mediate the action of tumor necrosis factor-alpha in isolated rat myenteric ganglia.Effects of PGE2 in guinea pig colonic myenteric ganglia.An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia.The spectrum of gastrointestinal toxicity and effect on disease activity of selective cyclooxygenase-2 inhibitors in patients with inflammatory bowel disease.Interleukin-1beta activates specific populations of enteric neurons and enteric glia in the guinea pig ileum and colon.Hyperoside attenuates dextran sulfate sodium-induced colitis in mice possibly via activation of the Nrf2 signalling pathway.Betulinic acid alleviates dextran sulfate sodium-induced colitis and visceral pain in mice.Intestinal anti-inflammatory activity of red wine extract: unveiling the mechanisms in colonic epithelial cells.CUEDC2 Protects Against Experimental Colitis and Suppresses Excessive Proliferation of Intestinal Mucosa.Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease.Cyclooxygenase-2 immunoexpression in intestinal epithelium and lamina propria of cats with inflammatory bowel disease and low grade alimentary lymphoma.Characterization of the EP receptor types that mediate longitudinal smooth muscle contraction of human colon, mouse colon and mouse ileum Antiinflammatory effect of Oldenlandia diffusa and its constituent, hentriacontane, through suppression of caspase-1 activation in mouse peritoneal macrophages The protective effect of Cassia obtusifolia on DSS-induced colitis

P2860

Q33681862-64397C5D-33AD-444C-BDC1-7C90B0255D3E Q33760727-76C68892-DFB5-4A45-92F4-0D5452FBBC9C Q34466925-72CE55A6-E55C-4807-BE43-2041C3D2BA3F Q35597403-3DDF1646-2BEC-4BC3-9869-155971AA79B9 Q35738909-13C9656A-D324-4992-9E61-B06362384661 Q36020015-AB739E01-5469-4B63-B1CA-F4E1D8274C37 Q36193382-8E53CCA1-A001-4CED-8A70-4076316AF9B9 Q36220453-5D52F8D8-7C81-4D6F-8C88-2BD3F5291031 Q37195197-D12D9A35-0AEC-46E9-BB5E-2EA65BD669AB Q38191576-45DD4359-0F12-48B1-8E9B-1166C6E07832 Q38227089-11A436D9-FD7E-452D-BF04-3D16E06DDE3E Q38276452-096D74DC-D34C-4A7D-930F-B3C46FC3ED1A Q40065740-8672560E-2308-4BAE-9AFA-D9DAA3664AA3 Q40783620-979EA563-7961-436A-A578-F17E121E7580 Q41638096-1802C5AC-560F-4A6C-993F-8E4033773225 Q41840456-D3E67A86-0EA1-4530-8886-4187B8D65D18 Q42460246-1D0DC197-F5BE-4FF8-8806-352A3B279458 Q42482491-3EBE9EB5-A977-45A6-B13B-102A7B243FE1 Q44185460-074F1277-3D2C-4499-926C-6AEBE3979F3F Q44465348-7907E439-43BB-4D4F-A082-184057FE8E06 Q45099623-7D71DC16-0A06-4B17-8FD3-5D16E58785DB Q46271526-18553FAB-21FA-429D-A312-AE4B249BDAF4 Q47377023-CC2B410F-D74A-4936-84B6-A191FBEB4222 Q47740173-85004F9B-5244-4A1A-B05F-D1D2A072C352 Q50498990-705E2023-8960-4E06-83CE-EE99C1F51635 Q53422806-BAD64171-B273-44BA-B416-50132B75FE2F Q53614343-51AAFCB0-754A-4D8E-8216-423C4068709A Q55308883-C495EF1B-18A5-4B49-B5D3-B588CEF88291 Q57120617-204035B6-F29E-42FA-9B25-D424C386113B Q57226279-748BA532-073B-40D8-80CB-A4460389E08B Q57226821-B1FAF4DA-2940-41A6-A2F3-11BD488F4937

P2860

Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease

http://www.wikidata.org/entity/Q28360085

description

2001 nî lūn-bûn

@nan

2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease

@ast

Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease

@en

Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease

@nl

type

label

Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease

@ast

Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease

@en

Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease

@nl

prefLabel

Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease

@ast

Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease

@en

Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease

@nl

P1433

Q28360085-72E7E3A7-B428-46B6-A2D9-6DC0AE700805

P1476

Q28360085-C292622E-DB6D-4CF6-8FCF-65D5E29F71F1

P2093

Q28360085-093D8D2E-97F0-4C88-B38B-97A70CEEA335

Q28360085-539AD731-EA47-4FAB-9A27-CB5701C140AC

Q28360085-8EEA1123-2E33-441A-AA43-691DCF7BF695

Q28360085-9F003535-660C-4514-8DBC-C28977DF54DC

Q28360085-EB425F82-33BD-4C6D-A9F4-86CE78F11339

P2860

Q28360085-003BCCFB-14C3-4CE8-826E-CD7489BFD4A8

Q28360085-26DA8BC3-28A5-4E55-B20B-B271045EC98C

Q28360085-3A2CEF50-A2E6-4786-BCEB-A760436540F4

Q28360085-52BFFA0A-6E37-4D24-B460-403C4DE17EAB

Q28360085-694DA00A-20B8-4295-A751-C6024B55CD86

Q28360085-956578B7-8AFF-4B8F-AC08-E96A9B891F3B

Q28360085-95A8DD00-73C6-4C71-878E-72768B07714D

Q28360085-96BAD4A0-5193-4C4E-A9EA-6161836A941A

Q28360085-A7A3826D-779F-4B14-AF89-7C994A46B879

Q28360085-B99E637B-D17F-4AF1-8A2B-301A4DEBB82B

P304

Q28360085-7480CBB6-8658-4981-A21C-CF03B9FB4610

P31

Q28360085-63EE3C31-F9C8-4659-B43B-ACAE35397203

P3181

Q28360085-6C96FAF6-5381-449E-B3D3-53998B474DA8

P356

Q28360085-0AB42418-0888-4134-8E1C-5A130ED6B174

P407

Q28360085-22964DEE-6227-43D2-9A0A-0AB78E5ACB79

P433

Q28360085-B9857B20-7210-443D-8F79-467E8051EE31

P478

Q28360085-3FBA6B84-49B2-443A-A340-D2F42A968FB1

P577

Q28360085-8DF7438A-B314-4988-ACFC-DAD8F08B71A3

P5875

Q28360085-0ACC9BDE-27F4-4653-8DC9-C4CD400C58F9

P698

Q28360085-54027136-5D21-4109-B6C8-C58F992EF180

P921

Q28360085-06ACDC86-1345-400C-8661-744B1DC3F29B

Q28360085-F343842D-0A00-4952-AA1F-B747391A196E

P932

Q28360085-A977EA56-7FD2-46C8-9040-92E503C26196

P3181

P356

P1433

P1476

Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease

@en

P2093

J O Hunter

http://www.w3.org/2001/XMLSchema#string

K Morgan

http://www.w3.org/2001/XMLSchema#string

P J Roberts

http://www.w3.org/2001/XMLSchema#string

R Miller

http://www.w3.org/2001/XMLSchema#string

S J Middleton

http://www.w3.org/2001/XMLSchema#string

P2860

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Abnormal gastrocolonic response in patients with ulcerative colitis.

Imbalance of prostacyclin and thromboxane synthesis in Crohn's disease.

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.

Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.

Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum.

The effect of intravenous prostaglandin F2 alpha and E2 on the motility of the sigmoid colon.

Colonic formation of soft feces in rabbits: a role for endogenous prostaglandins.

Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease.

P304

468-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2553099

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/GUT.48.4.468

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2001-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12084276

http://www.w3.org/2001/XMLSchema#string

P698

11247889

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

1728255

http://www.w3.org/2001/XMLSchema#string